Prof. Dr. Ramona Erber

Institute of Pathology

DICER1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case (2021) Erber R, Preidl R, Stöhr R, Haller F, Hartmann A, Kesting MR, Agaimy A Journal article Shifts in Macrophage as a prognostic Biomarker in Patients with luminal Breast Cancer - A Confirmatory Study (2021) Schnellhardt S, Segelhorst S, Erber R, Daniel C, Hartmann A, Fasching P, Beckmann M, et al. Conference contribution Identification and characterization of a GLMN splice site variant in a three-generation-family with glomuvenous malformations (2020) Skowronek D, Hebebrand M, Erber R, Agaimy A, Zweier C, Felbor U, Rath M Conference contribution HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment (2020) Würfel F, Hübner H, Häberle L, Gaß P, Hein A, Jud S, Hack C, et al. Journal article Tumour-infiltrating inflammatory cells in early breast cancer: An underrated prognostic and predictive factor? (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Journal article Piwi-like 1 and piwi-like 2 expression in breast cancer (2020) Erber R, Meyer J, Taubert H, Fasching P, Wach S, Häberle L, Gaß P, et al. Journal article Mammographic Density and Prognosis in Patients with primary Breast Cancer - Loss of Risk with increasing Age (2020) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Schulz-Wendtland R, et al. Conference contribution Accelerated Partial Breast Irradiation: Identification of High Risk Tumors in Early Hormone Receptor-positive Breast Cancer by Macrophage Shift Classification (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Conference contribution Accelerated Partial Breast Irradiation: Frequent non-professional Phagocytosis in Patients with early, Hormone Receptor-positive Breast Cancer is associated with good Survival (2020) Bauer M, Schnellhardt S, Rosahl MC, Erber R, Ott O, Fietkau R, Distel L Conference contribution Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020) Erber R, Hartmann A, Fasching P, Stöhr R, Beckmann M, Zentgraf M, Rübner M, et al. Conference contribution